Neurofeedback
78% Efficacy
neuroCare has the research and tools to personalise neurofeedback to the individual which science has shown to be effective in 3 in 4 cases (see Arns et al. 2012)
A short-term treatment Program
30 – 40 Neurofeedback sessions are usually needed for the brain to have learnt the new, beneficial patterns. Sessions held at least two times per week.
Medication Free
Neurofeedback is suited to children and adults who do not respond to traditional medication management for ADHD and sleep disorders.
What is Neurofeedback?
Neurofeedback is a treatment approach which measures brain activity via electrodes placed on the scalp, with activity then visualised on a monitor. This allows a person to voluntarily control brain activity by influencing the signal on the screen. Over a gradual learning process, the brain is rewarded for changing its activity to more appropriate patterns.
The importance of personalising Neurofeedback
The underlying causes of inattention, hyperactivity or sleep difficulties are not necessarily the same in two people. Because of this we create therapy programs which look at individual brain activity of the person, whether they be a child or adult. This is done by asking each patient or client to do a Quantitative EEG (QEEG) examination with psychometric assessment, to take into account biological, psychological and personal factors.
By doing a 7-day Actigraphy in the beginning as well, we can look at Sleep / Wake behaviours to see if this could explain some of the symptoms we are seeing. From this assessment the therapist will come up with a therapy program that is more likely to help the client (for scientific evidence on this see Arns et al. 2012).
The latest research
Van Doren et al. (2018). Sustained effects of neurofeedback in ADHD: A systematic review and meta-analysis. European Child & Adolescent Psychiatry.
We offer Neurofeedback across Sydney and Melbourne
Advantages of Personalised Neurofeedback
- non-invasive
- other than feeling fatigue after a training session, studies report no severe or adverse effects to doing Neurofeedback (this is shown in the multi-centre, placebo controlled trial by Strehl et al. 2017)
- self-efficacy through active participation
- short-term therapy programs, usually completed in 2 – 3 month
- following neuroCare protocols of a detailed pre-assessment, 3 in 4 people who do a full therapy program notice a significant improvement in symptoms of AD/HD (see Arns et al. 2012)
Who is Neurofeedback suitable for?
- adults, adolescents and children over 6 years old with inattention and impulsivity problems (ADHD) and/or sleep problems
- persons with sub-types of ADD/ADHD
- there is no exclusion criteria
